Darbepoetin alfa protects podocytes from apoptosis in vitro and in vivo
- 1 August 2007
- journal article
- Published by Elsevier in Kidney International
- Vol. 72 (4) , 489-498
- https://doi.org/10.1038/sj.ki.5002362
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activitiesProceedings of the National Academy of Sciences, 2006
- The cyclin-dependent kinase inhibitor p21 is required for TGF-β1-induced podocyte apoptosisKidney International, 2005
- Erythropoietin as an antiapoptotic, tissue-protective cytokineCell Death & Differentiation, 2004
- Retinoids as a potential treatment for experimental puromycin‐induced nephrosisBritish Journal of Pharmacology, 2003
- Ultraviolet light-induced DNA damage triggers apoptosis in nucleotide excision repair-deficient cells via Bcl-2 decline and caspase-3/-8 activationOncogene, 2001
- Role of intrinsic renal cells versus infiltrating cells in glomerular crescent formationKidney International, 1998
- Reversal of Anemia by Erythropoietin Therapy Retards the Progression of Chronic Renal Failure, Especially in Nondiabetic PatientsNephron, 1997
- Differential expression of transforming growth factor-β isoforms and receptors in experimental membranous nephropathyKidney International, 1996
- Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cellsBiochemical and Biophysical Research Communications, 1984